Altshuler Shaham LTD Axogen, Inc. Transaction History

Altshuler Shaham LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $32,637 - $46,545	-2,143 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $4,094 - $5,405	230 Added 12.02%	2,143 $46,000
Q1 2021 May 13, 2021	SELL	$17.18 - $22.6 $3,092 - $4,068	-180 Reduced 8.6%	1,913 $39,000
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $24,069 - $37,590	2,093 New	2,093 $37,000

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.